Aurora Cannabis Inc.
| NYSE: ACB | Healthcare / Drug Manufacturers / Canada |
| 1.61 | -0.0500 | -3.01% | Vol 11.79M | 1Y Perf -76.75% |
| Aug 11th, 2022 16:00 DELAYED |
| BID | 1.60 | ASK | 1.62 | ||
| Open | 1.69 | Previous Close | 1.66 | ||
| Pre-Market | - | After-Market | 1.63 | ||
| - - | 0.02 1.24% |
| Target Price | 3.14 | Analyst Rating | Hold 3.00 | |
| Potential % | 95.03 | Finscreener Ranking | ★+ 44.07 | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★+ 49.78 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★ 39.20 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 5.35 | Earnings Rating | Neutral | |
| Market Cap | 483.62M | Earnings Date | 26th Sep 2022 | |
| Alpha | -0.02 | Standard Deviation | 0.39 | |
| Beta | 3.11 |
Today's Price Range 1.601.77 | 52W Range 1.218.69 | 5 Year PE Ratio Range -34.4095.50 |
Summary:
Neutral
| Technical Indicators: | Buy |
| Moving Averages: | Neutral |
| Performance | |||
|---|---|---|---|
| 1 Week | 7.33% | ||
| 1 Month | 23.85% | ||
| 3 Months | -33.47% | ||
| 6 Months | -64.14% | ||
| 1 Year | -76.75% | ||
| 3 Years | -97.96% | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -45.48 | |||
ROE last 12 Months | -78.63 | |||
ROA (5Y Avg) | -36.90 | |||
ROA last 12 Months | -58.24 | |||
ROC (5Y Avg) | -13.10 | |||
ROC last 12 Months | -56.35 | |||
Return on invested Capital Q | -51.34 | |||
Return on invested Capital Y | -4.49 | |||
Assets Turnover | 0.10 | |||
Receivables Turnover | 3.70 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -0.30 | ||||
| 0.49 | ||||
| 3.28 | ||||
| - | ||||
| -5.00 | ||||
| -0.32 | ||||
| 0.89 | ||||
| 7.95 | ||||
| 369.64M | ||||
| Forward PE | -4.05 | |||
| PEG | -0.05 |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 4.00 | ||||
| 5.90 | ||||
| 0.24 | ||||
| 0.36 | ||||
| -16.00 | ||||
| Leverage Ratio | 1.30 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 24.50 | ||||
| -518.20 | ||||
| -474.70 | ||||
| -605.40 | ||||
| -64.42 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 131.82M | ||||
| 0.44 | ||||
| 1.01 | ||||
| 71.26 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q03 2022 | -0.16 | -1.04 | -550.00 |
| Q02 2022 | -0.17 | -0.42 | -147.06 |
| Q01 2022 | -0.18 | -0.09 | 50.00 |
| Q04 2021 | -0.22 | -0.21 | 4.55 |
| Q03 2021 | -0.17 | -0.24 | -41.18 |
| Q02 2021 | -0.19 | -0.28 | -47.37 |
| Q01 2021 | -0.24 | -0.64 | -166.67 |
| Q04 2020 | -0.30 | -0.13 | 56.67 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 6/2022 QR | -0.12 | 14.29 | Positive |
| 6/2022 FY | -1.65 | -106.25 | Negative |
| 9/2022 QR | -0.10 | 23.08 | Positive |
| 6/2023 FY | -0.37 | 19.57 | Positive |
| Next Report Date | 26th Sep 2022 |
| Estimated EPS Next Report | -0.12 |
| Estimates Count | 4 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 11.79M |
| Shares Outstanding | 300.39K |
| Shares Float | 297.75M |
| Trades Count | 21.70K |
| Dollar Volume | 19.73M |
| Avg. Volume | 10.41M |
| Avg. Weekly Volume | 10.35M |
| Avg. Monthly Volume | 9.65M |
| Avg. Quarterly Volume | 11.23M |
Aurora Cannabis Inc. (NYSE: ACB) stock closed at 1.61 per share at the end of the most recent trading day (a -3.01% change compared to the prior day closing price) with a volume of 11.79M shares and market capitalization of 483.62M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 2380 people. Aurora Cannabis Inc. CEO is Miguel Martin.
The one-year performance of Aurora Cannabis Inc. stock is -76.75%, while year-to-date (YTD) performance is -70.24%. ACB stock has a five-year performance of %. Its 52-week range is between 1.21 and 8.69, which gives ACB stock a 52-week price range ratio of 5.35%
Aurora Cannabis Inc. currently has a PE ratio of -0.30, a price-to-book (PB) ratio of 0.49, a price-to-sale (PS) ratio of 3.28, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -58.24%, a ROC of -56.35% and a ROE of -78.63%. The company’s profit margin is -64.42%, its EBITDA margin is -474.70%, and its revenue ttm is $131.82 Million , which makes it $0.44 revenue per share.
Of the last four earnings reports from Aurora Cannabis Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.12 for the next earnings report. Aurora Cannabis Inc.’s next earnings report date is 26th Sep 2022.
The consensus rating of Wall Street analysts for Aurora Cannabis Inc. is Hold (3), with a target price of $3.14, which is +95.03% compared to the current price. The earnings rating for Aurora Cannabis Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Aurora Cannabis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Aurora Cannabis Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 13.20, ATR14 : 0.15, CCI20 : 122.44, Chaikin Money Flow : 0.19, MACD : 0.01, Money Flow Index : 54.08, ROC : 16.08, RSI : 45.33, STOCH (14,3) : 84.09, STOCH RSI : 1.00, UO : 57.98, Williams %R : -15.91), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Aurora Cannabis Inc. in the last 12-months were:
Aurora Cannabis Inc.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
CEO: Miguel Martin
Telephone: +1 844 928-7672
Address: 4818 31 Street East, Edmonton T9E 0V6, AB, CA
Number of employees: 2 380
TipRanks News for ACB
Fri, 27 May 2022 13:26 GMT Aurora Cannabis Continues to Destroy Shareholder Value with Equity Financing
- TipRanks. All rights reserved.Fri, 13 May 2022 20:05 GMT Analysts Opinions Are Mixed on These Materials Stocks: Aurora Cannabis (ACB), Barrick Gold (GOLD) and First Quantum Minerals (OtherFQVLF)
- TipRanks. All rights reserved.Fri, 13 May 2022 12:48 GMT Aurora Cannabis (ACB) Gets a Hold Rating from MKM Partners
- TipRanks. All rights reserved.Wed, 11 May 2022 09:35 GMT Aurora Cannabis (ACB) Gets a Sell Rating from ATB Capital Markets
- TipRanks. All rights reserved.Wed, 04 May 2022 02:07 GMT Aurora Cannabis (ACB) Receives a Sell from Stifel Nicolaus
- TipRanks. All rights reserved.Sat, 12 Feb 2022 00:06 GMT Aurora Cannabis (ACB) Gets a Hold Rating from Piper Sandler
- TipRanks. All rights reserved.Fri, 11 Feb 2022 16:05 GMT Aurora Cannabis (ACB) Gets a Hold Rating from Cowen & Co.
- TipRanks. All rights reserved.Fri, 11 Feb 2022 13:25 GMT Aurora Cannabis (ACB) Receives a Hold from MKM Partners
- TipRanks. All rights reserved.Sun, 09 Jan 2022 11:49 GMT Investors Optimistic about Aurora as it Completes Shipment to Israel
- TipRanks. All rights reserved.
